Back to search

Article

Targeting IDH1-Mutated Oligodendroglioma with Acid Ceramidase Inhibitors

2024-04-29

Abstract excerpt

Oligodendroglioma is genetically defined as a tumor harboring isocitrate dehydrogenase 1 or 2 mutations (IDH1 mut /IDH2 mut ) and 1p/19q co-deletions. Previously, we reported that in IDH1 mut gliomas, D-2HG, the product of IDH1 mutant enzyme produces an increase in monounsaturated fatty acid levels that are incorporated into ceramides, tilting the S1P-to-ceramide rheostat toward apoptosis. Herein, we exploited...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
cafa43cc-fd90-5830-9aa8-1562284c9c5e
DOI
10.1101/2024.04.27.591426
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Targeting IDH1-Mutated Oligodendroglioma with Acid Ceramidase InhibitorsDOI 10.1101/2024.04.27.591426
Select a neighboring publication to make it the new centre.